The Crohn's Disease market size was worth USD 11.1 billion in 2022 and is expected to rise from USD 11.5 billion in 2023 to USD 15.37 billion by 2032, with a compound annual growth rate (CAGR) of 3.7% during the forecast period (2023-2032).
The research report profiles the global Crohn’s disease market in great detail and provides readers with a comprehensive overview of the market. The market’s historical growth trajectory, present conditions, and future growth prospects are studied in the report. The report provides a comprehensive overview of the market’s historical growth trajectory by detailing the historical stats regarding the market. Future projections are based on the detailed historical stats offered in the report. Based on this platform, future projections for the Crohn’s disease market’s growth trajectory over the forecast period are provided in the report. The report also profiles the leading players in the global Crohn’s disease market and gives readers a comprehensive analysis of the leading players in the global Crohn’s disease market. The report also profiles the major drivers and restraints affecting the global Crohn’s disease market. The factors making the market tick and those holding the market back are studied in detail in the report. The impact of the COVID-19 pandemic on the Crohn’s disease market trend is also assessed in the report.
Crohn’s disease is an inflammatory bowel disease and can affect any part of the digestive tract from the mouth to the anus. It is caused by a combination of immune, environmental, and bacterial factors in genetically predisposed individuals. It causes inflammation of the digestive tract, and can result in abdominal pain, severe diarrhea, fatigue, and weight loss. Malnutrition can be a result of Crohn's disease due to the severe diarrhea caused by the disease. Crohn's disease can’t be cured as of now, and can only be contained by various medications. Medications such as steroids and immunosuppressants can be used to slow the disease down, though they don’t completely eliminate it. Surgery may be required in patients in which the medications don’t have the desired effect. Crohn's disease also increases the individual’s risk of contracting colon cancer.
Competitive Leaderboard:
Leading players in the global Crohn's disease market include Bristol-Myers Squibb, F. Hoffman-La Roche, Eli Lilly and Company, Ferring BV, UCB SA, Takeda Pharmaceutical Co. Ltd., Amgen Inc., Bayer AG, AbbVie Inc., Allergan, Pfizer Inc., and Johnson & Johnson Services Inc.
Segmentation:
The global Crohn's disease market is segmented on the basis of type, treatment, end use, and region.
By type, the global Crohn's disease market is segmented into ileocolitis, ileitis, granulomatous colitis, gastroduodenal Crohn’s disease, jejunoileitis, and perianal Crohn’s disease.
By treatment, the global Crohn's disease market is segmented into non-surgical and surgical. The non-surgical segment is further sub-segmented into anti-inflammatory, immune system suppressors, antibiotics, and others. The anti-inflammatory segment is classified as corticosteroids and oral 5-aminosalicylates. The immune system suppressors segment is further sub-segmented into Azathioprine, Mercaptopurine, TNF inhibitors, Methotraxate, Natalizumab, Vedolizumab, and Ustekinumab. The anti-inflammatory segment dominates the global Crohn's disease market as of 2018, due to the higher efficacy of anti-inflammatory medication as compared to analgesics and immunosuppressants. The immune system suppressors segment is expected to exhibit the highest growth rate over the forecast period. The reduction in surgery numbers and hospitalization rates is a major driver for the same.
By end use, the global Crohn's disease market is segmented into hospitals and clinics, research institutes, diagnostic centers, and others. Hospitals and clinics hold the dominant share in the global Crohn's disease market and are likely to remain the dominant market segment over the forecast period.
Regional Analysis:
The Americas dominate the global Crohn's disease market, followed by Europe. The growing prevalence of Crohn's disease in North America and the growing awareness about the disease in the region are the major drivers for the Crohn's disease market in the Americas. North America is the leading regional segment within the America, led by the U.S. Europe is also likely to hold an important share in the global Crohn's disease market over the forecast period.
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
